Abstract:Background: Reactive Oxygen Species (ROS) is a key factor in the pathogenesis of osteoporosis (OP) primarily characterized by excessive osteoclast activity. Active fraction of Polyrhachis vicina Rogers (AFPR) exerts antioxidant effects and possesses extensive promising therapeutic effects in various conditions, however, its function in osteoclastogenesis and OP is unknown. Purpose: The aim of this study is to elucidate the cellular and molecular mechanisms of AFPR in OP. Study design and methods: CCK8 assay was used to evaluate the cell viability under AFPR treatment. TRAcP staining, podosome belts staining and bone resorption were used to test the effect of AFPR on osteoclastogenesis. Immunofluorescence staining was used to observe the effect of AFPR on ROS production. si-RNA transfection, coimmunoprecipitation and Western-blot were used to clarify the underlying mechanisms. Further, an ovariectomy (OVX) -induced OP mice model was used to identify the effect of AFPR on bone loss using Micro-CT scanning and histological examination. Results: In the present study, AFPR inhibited osteoclast differentiation and bone resorption induced by nuclear factor-κB receptor activator (NF-κB) ligand (RANKL) in dose-/ time-dependent with no cytotoxicity. Meanwhile, AFPR decreased RANKL-mediated ROS levels and enhanced ROS scavenging enzymes. Mechanistically, AFPR promoted proteasomal degradation of TRAF6 by significantly upregulating its K48-linked ubiquitination, subsequently inhibiting NFATc1 activity. We further observed that tripartite motif protein 38 (TRIM38) could mediate the ubiquitination of TRAF6 in response to RANKL. Moreover, TRIM38 could negatively regulate the RANKL pathway by binding to TRAF6 and promoting K48-linked polyubiquitination. In addition, TRIM38 deficiency rescued the inhibition of AFPR on ROS and NFATc1 activity and osteoclastogenesis. In line with these results, AFPR reduced OP caused by OVX through ameliorating osteoclastogenesis. Conclusion: AFPR alleviates ovariectomized-induced bone loss via suppressing ROS and NFATc1 by targeting Trim38 mediated proteasomal degradation of TRAF6. The research offers innovative perspectives on AFPR's suppressive impact in vivo OVX mouse model and in vitro, and clarifies the fundamental mechanism.

TRIM33 protects osteoblasts from oxidative stress‐induced apoptosis in osteoporosis by inhibiting FOXO3a ubiquitylation and degradation

TRIM33 is essential for osteoblast proliferation and differentiation via BMP pathway

Simvastatin Protects Human Osteosarcoma Cells from Oxidative Stress-Induced Apoptosis Through Mitochondrial-Mediated Signaling

Trim21 depletion alleviates bone loss in osteoporosis via activation of YAP1/β-catenin signaling

Trim21 depletion alleviates bone loss in osteoporosis via activation of YAP1/-catenin signaling

TRIM65 Promotes Osteogenic Differentiation by Regulating the PI3K/AKT Signaling Pathway

TRIM16 mitigates impaired osteogenic differentiation and antioxidant response in D-galactose-induced senescent osteoblasts

TRIM21 silencing inhibits the apoptosis and expedites the osteogenic differentiation of dexamethasone‐induced MC3T3‐E1 cells by activating the Keap1/Nrf2 pathway

gCTRP3 inhibits oophorectomy‐induced osteoporosis by activating the AMPK/SIRT1/Nrf2 signaling pathway in mice

TRIM59 Attenuates IL-1β-driven Cartilage Matrix Degradation in Osteoarthritis Via Direct Suppression of NF-κB and JAK2/STAT3 Signaling Pathway.

TRIM38 Protects Chondrocytes from IL-1β-induced Apoptosis and Degeneration Via Negatively Modulating Nuclear Factor (Nf)-Κb Signaling.

Oxidative Stress Stimulates Testicular Orphan Receptor 4 Through Forkhead Transcription Factor Forkhead Box O3a

TRIM32 regulates mitochondrial mediated ROS levels and sensitizes the oxidative stress induced cell death

Tanshinol Attenuates the Deleterious Effects of Oxidative Stress on Osteoblastic Differentiation Via Wnt/FoxO3a Signaling

Silencing FOXO1 attenuates dexamethasone-induced apoptosis in osteoblastic MC3T3-E1 cells.

Active fraction of Polyrhachis vicina (Rogers) inhibits osteoclastogenesis by targeting Trim38 mediated proteasomal degradation of TRAF6

Oxidative Stress Induces Downregulation of TP53INP2 and Suppresses Osteogenic Differentiation of BMSCs During Osteoporosis Through the Autophagy Degradation Pathway.

FoxO3 Regulates Mouse Bone Mesenchymal Stem Cell Fate and Bone-Fat Balance During Skeletal Aging.

FOXO1 differentially regulates bone formation in young and aged mice

MicroRNA-532-5p is implicated in the regulation of osteoporosis by forkhead box O1 and osteoblast differentiation

Cholestane-3beta,5alpha,6beta-triol inhibits osteoblastic differentiation and promotes apoptosis of rat bone marrow stromal cells.